Neonatal Dose Individualization

Neonatal Dose Individualization is a clinical pharmacological approach that tailors drug dosage regimens to individual newborns based on physiological, genetic, and developmental factors unique to the neonatal period, thereby optimizing therapeutic efficacy and minimizing toxicity.

5

Publications

127

Citations

44

Authors

34

Institutions

Publications per year

2017–2026

2

Authors

44

  1. ÉJ
    Évelyne Jacqz-Aigrain

    Hôpital Robert-Debré, France

    2 publications · 53 citations

    2

    h-index

  2. WZ
    Wei Zhao

    Shandong University, China

    2 publications · 53 citations

    2

    h-index

  3. SL
    Stéphanie Leroux

    Assistance Publique – Hôpitaux de Paris, France

    2 publications · 53 citations

    2

    h-index

  4. MB
    Marie‐Jeanne Boutroy

    Inserm, France

    1 publications · 24 citations

    1

    h-index

  5. IL
    Irja Lutsar

    University of Tartu, Estonia

    1 publications · 31 citations

    1

    h-index

1–5 of 44

Venues

  1. Neonatology

    1 publications · 24 citations

    1

    h-index

  2. 1

    h-index

  3. Toxicology and Applied Pharmacology

    TAAP · 1 publications · 20 citations

    1

    h-index

  4. Antimicrobial Agents and Chemotherapy

    AAC · 1 publications · 22 citations

    1

    h-index

  5. Clinical Pharmacokinetics

    1 publications · 31 citations

    1

    h-index

1–5